Oragenics
OGEN • AMEX
Oragenics is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Janet Huffman, with a market cap of $2.3M.
CEOJanet Huffman
Next Earnings
Upcoming earnings announcement for Oragenics
Date
Friday, May 8, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
Earnings History
Past 12 earnings reports for Oragenics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | Q4 2025 | $0.60 | — | - | — |  10-K |
| Nov 7, 2025 | Q3 2025 | -$1.96 | — | - | — | 10-Q |
| Aug 8, 2025 | Q2 2025 | -$3.10 | — | - | — | 10-Q |
| May 9, 2025 | Q1 2025 | -$0.12 | — | - | — | 10-Q |
| Mar 14, 2025 | Q4 2024 | -$0.11 | — | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.38 | — | - | — | 10-Q |
| Aug 9, 2024 | Q2 2024 | -$0.51 | — | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$0.70 | — | - | — | 10-Q |
| Mar 29, 2024 | Q4 2023 | -$5.48 | — | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.85 | — | $7.5K | — | — |
| Aug 14, 2023 | Q2 2023 | -$1.51 | — | $13.2K | — | 10-Q |
| May 12, 2023 | Q1 2023 | -$1.41Est: -$3.00 | +53.0% | $17.0KEst: $17.0K | +0.1% | — |